{"organizations": [], "uuid": "871daef91e2821141a32eeba1c9a72b39071c26c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-q1-gaa/brief-boston-scientific-announces-q1-gaap-earnings-per-share-0-21-idUSASC09X8S", "country": "US", "domain_rank": 408, "title": "BRIEF-Boston Scientific Announces Q1 GAAP Earnings Per Share $0.21", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T18:40:00.000+03:00", "replies_count": 0, "uuid": "871daef91e2821141a32eeba1c9a72b39071c26c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-q1-gaa/brief-boston-scientific-announces-q1-gaap-earnings-per-share-0-21-idUSASC09X8S", "ord_in_thread": 0, "title": "BRIEF-Boston Scientific Announces Q1 GAAP Earnings Per Share $0.21", "locations": [], "entities": {"persons": [], "locations": [{"name": "boston", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "boston scientific corp", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Boston Scientific Corp:\n* BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2018\n* SEES FY 2018 REVENUE $9.75 BILLION TO $9.9 BILLION * Q1 SALES $2.379 BILLION VERSUS I/B/E/S VIEW $2.34 BILLION\n* Q1 EARNINGS PER SHARE VIEW $0.32 — THOMSON REUTERS I/B/E/S\n* SEES Q2 2018 SALES $2.45 BILLION TO $2.5 BILLION * QTRLY CARDIAC RHYTHM MANAGEMENT SALES $493 MILLION VERSUS $463 MILLION REPORTED LAST YEAR\n* FY2018 REVENUE VIEW $9.75 BILLION — THOMSON REUTERS I/B/E/S\n* Q2 REVENUE VIEW $2.44 BILLION — THOMSON REUTERS I/B/E/S * QTRLY INTERVENTIONAL CARDIOLOGY SALES $645 MILLION VERSUS $590 MILLION REPORTED LAST YEAR\n* BOSTON SCIENTIFIC - SEES 2018 ADJUSTED EARNINGS PER SHARE, EXCLUDING ITEMS IN A RANGE OF $1.37 TO $1.41 PER SHARE\n* BOSTON SCIENTIFIC - SEES Q2 2018 ADJUSTED EARNINGS PER SHARE, EXCLUDING ITEMS IN A RANGE OF $0.33 TO $0.35 PER SHARE\n* SEES FY 2018 GAAP EARNINGS PER SHARE $0.90 TO $0.94 * Q2 EARNINGS PER SHARE VIEW $0.35 — THOMSON REUTERS I/B/E/S\n* FY2018 EARNINGS PER SHARE VIEW $1.37 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T18:40:00.000+03:00", "crawled": "2018-04-26T20:31:04.014+03:00", "highlightTitle": ""}